Suchergebnisse - "Gillot, Constant"

PubPharm (18)

1

Assessment of the neutralizing antibody response in Omicron breakthrough cases in healthcare workers who received the homologous booster of Moderna mRNA-1273

enthalten in: Virology | 2024

von Gillot, C. | Tré-Hadry, M. | Cupaiolo, R. | +6

2

Peri-infection titers of neutralizing and binding antibodies as a predictor of COVID-19 breakthrough infections in vaccinated healthcare professionals : importance of the timing

enthalten in: Clinical chemistry and laboratory medicine | 2023

von Gillot, C. | Bayart, J. | Closset, M. | +5

3

Vaccine-induced binding and neutralizing antibodies against Omicron 6 months after a homologous BNT162b2 booster

enthalten in: Journal of medical virology | 2023

von Favresse, J. | Gillot, C. | Bayart, J. | +6

4

Serum SARS-CoV-2 Antigens for the Determination of COVID-19 Severity

enthalten in: Viruses | 2022

von Favresse, J. | Bayart, J. | David, C. | +8

5

NETosis and Nucleosome Biomarkers in Septic Shock and Critical COVID-19 Patients : An Observational Study

enthalten in: Biomolecules | 2022

von Morimont, L. | Dechamps, M. | David, C. | +12

6

Lung Transplant Recipients Immunogenicity after Heterologous ChAdOx1 nCoV-19-BNT162b2 mRNA Vaccination

enthalten in: Viruses | 2022

von Catry, E. | Favresse, J. | Gillot, C. | +8

7

Spike vs. nucleocapsid serum antigens for COVID-19 diagnosis and severity assessment

enthalten in: Clinical chemistry and laboratory medicine | 2022

von Favresse, J. | Bayart, J. | David, C. | +4

8

Identification of SARS-CoV-2 Neutralizing Antibody with Pseudotyped Virus-based Test on HEK-293T hACE2 Cells

enthalten in: Bio-protocol | 2022

von Gillot, C. | Favresse, J. | Maloteau, V. | +2

9

Dynamics of Neutralizing Antibody Responses Following Natural SARS-CoV-2 Infection and Correlation with Commercial Serologic Tests. A Reappraisal and Indirect Comparison with Vaccinated Subjects

enthalten in: Viruses | 2021

von Gillot, C. | Favresse, J. | Maloteau, V. | +2

10

Post-SARS-CoV-2 vaccination specific antibody decrease - Thresholds for determining seroprevalence and seroneutralization differ

enthalten in: The Journal of infection | 2021

von Douxfils, J. | Gillot, C. | Mullier, F. | +1

CommentOn: J Infect. 2021 Jul 29;:null. - PMID 34332018